AAAAAA
Results:
1-11
|
Results: 11
Authors:
McLaughlin, PMJ
Kroesen, BJ
Harmsen, MC
de Leij, LFMH
Citation: Pmj. Mclaughlin et al., Cancer immunotherapy: insights from transgenic animal models, CR R ONC H, 40(1), 2001, pp. 53-76
Authors:
Chalfant, CE
Ogretmen, B
Galadari, S
Kroesen, BJ
Pettus, BJ
Hannun, YA
Citation: Ce. Chalfant et al., FAS activation induces dephosphorylation of SR proteins - Dependence on the de novo generation of ceramide and activation of protein phosphatase 1, J BIOL CHEM, 276(48), 2001, pp. 44848-44855
Authors:
Kroesen, BJ
Pettus, B
Luberto, C
Busman, M
Sietsma, H
de Leij, L
Hannun, YA
Citation: Bj. Kroesen et al., Induction of apoptosis through B-cell receptor cross-linking occurs via denovo generated C16-ceramide and involves mitochondria, J BIOL CHEM, 276(17), 2001, pp. 13606-13614
Authors:
McLaughlin, PMJ
Harmsen, MC
Dokter, WHA
Kroesen, BJ
van der Molen, H
Brinker, MGL
Hollema, H
Ruiters, MHJ
Buys, CHCM
de Leij, LFMH
Citation: Pmj. Mclaughlin et al., The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: A new model to study carcinoma-directed immunotherapy, CANCER RES, 61(10), 2001, pp. 4105-4111
Authors:
Withoff, S
Bijman, MNA
Stel, AJ
Delahaye, L
Calogero, A
de Jonge, MWA
Kroesen, BJ
de Leij, L
Citation: S. Withoff et al., Characterization of BIS20x3, a bi-specific antibody activating and retargeting T-cells to CD20-positive B-cells, BR J CANC, 84(8), 2001, pp. 1115-1121
Authors:
Schroder, CP
Kroesen, BJ
de Leij, LFMH
de Vries, EGE
Citation: Cp. Schroder et al., Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1, CLIN CANC R, 6(6), 2000, pp. 2521-2527
Authors:
Molema, G
Kroesen, BJ
Helfrich, W
Meijer, DKF
de Leij, LFMH
Citation: G. Molema et al., The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy, J CONTR REL, 64(1-3), 2000, pp. 229-239
Authors:
Helfrich, W
Haisma, HJ
Magdolen, V
Luther, T
Bom, VJJ
Westra, J
van der Hoeven, R
Kroesen, BJ
Molema, G
de Leij, L
Citation: W. Helfrich et al., A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions, J IMMUNOL M, 237(1-2), 2000, pp. 131-145
CD3 directed bispecific antibodies induce increased lymphocyte-endothelialcell interactions in vitro
Authors:
Molema, G
Tervaert, JWC
Kroesen, BJ
Helfrich, W
Meijer, DKF
de Leij, LFMH
Citation: G. Molema et al., CD3 directed bispecific antibodies induce increased lymphocyte-endothelialcell interactions in vitro, BR J CANC, 82(2), 2000, pp. 472-479
Authors:
McLaughlin, PMJ
Kroesen, BJ
Dokter, WHA
van der Molen, H
de Groot, M
Brinker, MGL
Kok, K
Ruiters, MHJ
Buys, CHCM
de Leij, LFMH
Citation: Pmj. Mclaughlin et al., An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy, CANCER IMMU, 48(6), 1999, pp. 303-311
Authors:
Helfrich, W
Kroesen, BJ
Molema, G
de Leij, L
Citation: W. Helfrich et al., Recent developments in the construction of bispecific antibodies, DEV HEMATOL, 33, 1998, pp. 103-118
Risultati:
1-11
|